- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-dimer
- Ligands
- 4 x P5S: O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine
- 4 x LBN: 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
LBN.3: 22 residues within 4Å:- Chain A: Q.285, A.288, G.289, Y.291, F.293, I.296, W.297, T.331, T.334, Y.338, Y.341, L.342, D.344, C.347, K.348, C.354, F.357, G.358, L.388, L.389
- Chain B: I.43
- Ligands: LBN.8
12 PLIP interactions:11 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:A.288, A:Y.291, A:F.293, A:F.293, A:F.293, A:I.296, A:W.297, A:T.331, A:T.334, A:L.388, B:I.43
- pi-Cation interactions: A:Y.341
LBN.7: 14 residues within 4Å:- Chain A: P.40, H.41, T.42, I.43, T.44, S.47, I.50
- Chain B: L.292, Y.341, K.348, R.349, V.350, F.362
- Ligands: LBN.11
9 PLIP interactions:7 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:I.43, A:I.50, A:I.50, B:L.292, B:F.362
- Hydrogen bonds: A:I.43, A:T.44, A:S.47
- Salt bridges: A:H.41
LBN.8: 14 residues within 4Å:- Chain A: L.292, Y.341, K.348, R.349, V.350, F.362
- Chain B: P.40, H.41, T.42, I.43, T.44, S.47, I.50
- Ligands: LBN.3
9 PLIP interactions:7 interactions with chain B, 2 interactions with chain A- Hydrophobic interactions: B:I.43, B:I.50, B:I.50, A:L.292, A:F.362
- Hydrogen bonds: B:I.43, B:T.44, B:S.47
- Salt bridges: B:H.41
LBN.11: 22 residues within 4Å:- Chain A: I.43
- Chain B: Q.285, A.288, G.289, Y.291, F.293, I.296, W.297, T.331, T.334, Y.338, Y.341, L.342, D.344, C.347, K.348, C.354, F.357, G.358, L.388, L.389
- Ligands: LBN.7
12 PLIP interactions:11 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:A.288, B:Y.291, B:F.293, B:F.293, B:F.293, B:I.296, B:W.297, B:T.331, B:T.334, B:L.388, A:I.43
- pi-Cation interactions: B:Y.341
- 2 x 01: (2R)-3-{[(S)-hydroxy{[(1R,2R,3R,4R,5R,6S)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}propane-1,2-diyl dihexadecanoate
01.4: 19 residues within 4Å:- Chain A: F.36, F.37, R.39, P.40, H.41, T.42, T.44, L.45, F.48, V.85, L.86, A.87, F.88, H.97, R.102
- Chain B: K.18, F.21, R.22, R.349
17 PLIP interactions:8 interactions with chain A, 9 interactions with chain B- Hydrophobic interactions: A:T.44, A:L.45, A:F.48, A:V.85
- Hydrogen bonds: A:H.41, A:A.87, B:K.18, B:E.26, B:R.349, B:R.349
- Salt bridges: A:H.97, A:R.102, B:K.18, B:R.349, B:R.349
- Water bridges: B:N.25, B:N.25
01.12: 19 residues within 4Å:- Chain A: K.18, F.21, R.22, R.349
- Chain B: F.36, F.37, R.39, P.40, H.41, T.42, T.44, L.45, F.48, V.85, L.86, A.87, F.88, H.97, R.102
17 PLIP interactions:8 interactions with chain B, 9 interactions with chain A- Hydrophobic interactions: B:T.44, B:L.45, B:F.48, B:V.85
- Hydrogen bonds: B:H.41, B:A.87, A:K.18, A:E.26, A:R.349, A:R.349
- Salt bridges: B:H.97, B:R.102, A:K.18, A:R.349, A:R.349
- Water bridges: A:N.25, A:N.25
- 2 x 6OU: [(2~{R})-1-[2-azanylethoxy(oxidanyl)phosphoryl]oxy-3-hexadecanoyloxy-propan-2-yl] (~{Z})-octadec-9-enoate
6OU.5: 9 residues within 4Å:- Chain A: F.168, G.171, H.172, G.175, A.315, W.321, I.324, L.325
- Ligands: P5S.1
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:I.324
- Salt bridges: A:H.172
6OU.13: 9 residues within 4Å:- Chain B: F.168, G.171, H.172, G.175, A.315, W.321, I.324, L.325
- Ligands: P5S.9
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:I.324
- Salt bridges: B:H.172
- 2 x CA: CALCIUM ION
CA.6: 4 residues within 4Å:- Chain A: E.197, E.200, Q.217, D.221
3 PLIP interactions:3 interactions with chain A- Metal complexes: A:E.197, A:E.200, A:D.221
CA.14: 4 residues within 4Å:- Chain B: E.197, E.200, Q.217, D.221
3 PLIP interactions:3 interactions with chain B- Metal complexes: B:E.197, B:E.200, B:D.221
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Long, T. et al., Molecular insights into human phosphatidylserine synthase 1 reveal its inhibition promotes LDL uptake. Cell (2024)
- Release Date
- 2024-09-04
- Peptides
- Phosphatidylserine synthase 1: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-dimer
- Ligands
- 4 x P5S: O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine
- 4 x LBN: 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
- 2 x 01: (2R)-3-{[(S)-hydroxy{[(1R,2R,3R,4R,5R,6S)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}propane-1,2-diyl dihexadecanoate
- 2 x 6OU: [(2~{R})-1-[2-azanylethoxy(oxidanyl)phosphoryl]oxy-3-hexadecanoyloxy-propan-2-yl] (~{Z})-octadec-9-enoate
- 2 x CA: CALCIUM ION
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Long, T. et al., Molecular insights into human phosphatidylserine synthase 1 reveal its inhibition promotes LDL uptake. Cell (2024)
- Release Date
- 2024-09-04
- Peptides
- Phosphatidylserine synthase 1: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.